DEVELOPMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPLICATIONS

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sphere of biopharmaceuticals, giving promising progress throughout various clinical and industrial applications. With its structural similarity to By natural means derived human serum albumin, OsrHSA offers a safer, more dependable different for therapeutic use,